Concerning the latter aspect, Takenaga and colleagues showed that S100A4 down-regulation could influence tumor migration both in vitro and in vivo, suggesting that the protein was involved in the motility and invasiveness of GBM. The gene discussed is S100A4; the disease is neoplasm.